plerixafor has been researched along with Respiratory Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, MW; Barrett, JE; Chen, X; Cowan, A; Doura, M; Eisenstein, EM; Eisenstein, TK; Geller, EB; Inan, S; Meissler, JJ; Rawls, SM; Tallarida, C; Watson, M | 1 |
1 other study(ies) available for plerixafor and Respiratory Insufficiency
| Article | Year |
|---|---|
Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression.
Topics: Analgesia; Analgesics, Opioid; Animals; Benzylamines; Cyclams; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Male; Maraviroc; Morphine; Nociception; Nociceptive Pain; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Chemokine; Respiratory Insufficiency; Thiazoles | 2021 |